Pharming (PHAR) Income After Tax (2020 - 2026)
Pharming's Income After Tax came in at $40.00 for Q3 2026, up 123.5% from $17.90 a year earlier but down 100.0% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Income After Tax (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Pharming reported Income After Tax of -$9.63 million; for FY2025, it was $2.54 million.
- Income After Tax carries a five-year compound annual growth rate of -41.7% (FY2020 to FY2025).
- Going back by year, Income After Tax was -$18.55 million in FY2024, -$10.55 million in FY2023, $37.9 million in FY2022 (+136.9%) and $16 million in FY2021 (-57.6%).
- The five-year range for quarterly Income After Tax is -$21.6 million (Q4 2022) to $21.59 million (Q2 2022).
- Year-over-year, Income After Tax increased in 1 of the last four quarters, with an average decline of 29.9%.
- The fastest year-over-year change in Income After Tax over five years came in Q3 2026 (growth of 123.5%), and the weakest in Q3 2025 (a decline of 100.0%).
- Business Quant data shows PHAR's Income After Tax at $147,000 (Q2 2026), -$9.78 million (Q1 2026) and $4.30 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Pharming | 927.62 Mn | 229.29 Mn | 102.20 | 40.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 40.00 |
| Jun 30, 2026 | 147,000.00 |
| Mar 31, 2026 | -4.29 Mn |
| Dec 31, 2025 | 4.30 |
| Sep 30, 2025 | 17.90 |
| Jun 30, 2025 | 920,000.00 |
| Mar 31, 2025 | -8.69 Mn |
| Dec 31, 2024 | 10.50 |
| Sep 30, 2024 | 4.01 Mn |
| Jun 30, 2024 | -19.70 Mn |
| Mar 31, 2024 | -20.80 Mn |
| Dec 31, 2023 | -900,000.00 |
| Sep 30, 2023 | 3.15 Mn |
| Jun 30, 2023 | -15.69 Mn |
| Mar 31, 2023 | -21.14 Mn |
| Dec 31, 2022 | -21.60 Mn |
| Sep 30, 2022 | 9.50 Mn |
| Jun 30, 2022 | 21.59 Mn |
| Mar 31, 2022 | 3.60 Mn |
| Dec 31, 2021 | 5.70 Mn |
API Access
Pharming Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();